Novavax’s Nuvaxovid Receives Expanded Authorization for COVID-19 in Canada
Shots: Nuvaxovid (NVX-CoV2373) received expanded authorization from Health Canada...
Pfizer and BioNTech Reports P-II/III Trial Results of Omicron BA.4/BA.5-Adapted Bivalent Booster for COVID-19
Shots: The P-II/III trial to evaluate Omicron BA.4/BA.5-Adapted Bivalent Booster (...
Pfizer and BioNTech Initiate P-I Study of mRNA-Based Combination Vaccine for the Treatment of COVID-19 and Influenza
Shots: The first participant has been dosed in a P-I trial evaluating the safety,...
Rigel Reports P-III (FOCUS) Trial Results of Fostamatinib for COVID-19 in High Risk Hospitalized Patients
Shots: The P-III (FOCUS) trial evaluates fostamatinib (BID) + SoC vs PBO + SoC in...
Arcturus Collaborated with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
Shots: Arcturus will receive $200M up front, ~$1.3B in development milestones &...
Pfizer and BioNTech Receive the EMA’s CHMP Positive Opinion for Comirnaty to Treat COVID-19 in Children Aged 6 Months to ≤5 Years
Shots: The EMA’s CHMP has adopted the positive opinion recommending marketin...
